COVID variants do not stop C. diff. Awareness walks around the world – Le Journal

TEANECK, NJ, September 20, 2021 (SEND2PRESS NEWSWIRE) – The C Diff Foundation announced today that the 5th edition of the Global C. diff. The awareness walks will be held on demand, live and in person at Sims Park, New Port Richey, FL, and Brown Street Park Complex, Spring City, PA, and Milton A. Votee, Teaneck, NJ. This year’s annual events will take place on Saturday, September 25, 2021, from 9:00 a.m. to 12:00 p.m. EDT. Learn more at: https://www.cdiffwalks.com

Proceeds from the events will benefit the C Diff Foundation’s mission to educate and advocate for C. difficile infection prevention, treatments, clinical trials and environmental safety worldwide. In these unprecedented times, the C Diff Foundation is effectively adapting to overcome the many obstacles developing from this global virus and the variants of SARS-CoV-2 that have emerged and circulated around the world throughout the COVID-19 pandemic.

C. diff. Infections are one of the major healthcare-associated infections facing local communities around the world. According to the Centers for Disease Control and Prevention (CDC), Clostridioides difficile infection (C. diff., C. difficile) (formerly known as Clostridium difficile) “has become the most common microbial cause of nosocomial infections. in the USA. hospitals and costs up to $ 4.8 billion annually in excess health care costs for acute care facilities alone. Statistics provided by the CDC suggest that C. difficile causes nearly 500,000 infections in patients in the United States each year. In a study noted by the CDC, among infected patients, nearly 29,000 died within 30 days of diagnosis, and more than half of those deaths (15,000) were directly attributable to C. difficile infection.

“The volunteer members of the C Diff Foundation are passionate about improving the lives of patients, families and caregivers who have been affected by C. diff. infections around the world, ”says Nancy C. Caralla, Founding President and Executive Director of the C Diff Foundation. “To C. diff in person. Awareness steps, a safety distance will be maintained and hand sanitizer will be available to ensure a safe outdoor event. “Let’s Walk” features educational information shared by healthcare professionals, and C. diff. Survivors, via on-demand walks and live streaming options located on the event’s dedicated website: https://cdiffwalks.com. “

Thank you, Ferring Pharmaceuticals, for being the global sponsor of the 5th edition of Global C. diff. Awareness walks. Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world start families and live better lives. Ferring is a leader in reproductive medicine and maternal health, as well as the specialty areas of gastroenterology and urology. Ferring is committed to exploring the crucial link between the microbiome and human health, starting with the threat of recurrent C. difficile infection. With the 2018 acquisition of Rebiotix and several other alliances, Ferring is a global leader in microbiome research, developing new microbiome-based therapies to address important unmet needs and help people experience better life. For more information, visit https://www.ferringusa.com.

We also extend our thanks to Seres Therapeutics, Inc. for being the diamond sponsor of the 5th edition of Global C. diff. Awareness walks.

Seres Therapeutics, Inc. is a leading microbiome therapy company developing a new class of multifunctional bacterial consortia designed to functionally interact with host cells and tissues to treat disease. Seres’ SER-109 program achieved the first positive pivotal clinical results for a microbiome-targeted drug candidate and achieved breakthrough therapy and orphan drug designations from the FDA. The SER-109 program is under development for the treatment of recurrent C. difficile infections and has the potential to become an FDA approved microbiome therapy. Seres is evaluating SER-301 in a phase 1b study in patients with ulcerative colitis and SER-155 in a phase 1b study to treat gastrointestinal infections, bacteremia and graft versus host disease. For more information, please visit https://www.serestherapeutics.com.

About the C Diff Foundation:

The C Diff Foundation, a 501 (c) (3) nonprofit, is the leading patient and healthcare organization that educates and advocates for the prevention, treatment, clinical trials, diagnoses of C. difficile (Clostridioides difficile, C. diff., CDI, CDAD), environmental assistance and safety worldwide. Their mission continues to move forward and expand through research conducted by government, industry and academia, strengthening advocacy on behalf of patients, families, caregivers, healthcare professionals and researchers from all over the world. For more information: https://cdifffoundation.org/

Follow the C Diff Foundation: Twitter @cdiffFoundation # cdiffwalks2021 # cdiff2021

C Diff Foundation ™ is a registered trademark of C Diff Foundation, created in 2012 in the United States

CONTACT WITH THE MEDIA:

Kathy Bischoff, World March Committee

[email protected]

(727) 205-3922

MULTIMEDIA:

IMAGE link for media: https://www.Send2Press.com/300dpi/21-0920s2p-cdf-events-300dpi.jpg

NEWS SOURCE: C Diff Foundation

This press release has been published on behalf of the information source (C Diff Foundation) which is solely responsible for its accuracy, by Send2Press® Newswire. Information is believed to be accurate but is not guaranteed. Story ID: 75210 APDF-R8.2

&Copy; 2021 Send2Press®, a press release and electronic marketing service from NEOTROPE®, California, United States.

To view the original version visit: https://www.send2press.com/wire/covid-variants-do-not-stop-c-diff-awareness-walks-worldwide/

Disclaimer: The contents of this press release were not created by The Associated Press (AP).

About Leslie Schwartz

Check Also

Jim Kerr will be honored by the State | News, Sports, Jobs

COLUMBUS — A retired longtime local educator who founded the Beaver …

Leave a Reply

Your email address will not be published.